Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor–positive metastatic breast cancer: Patient-reported outcomes in the PEARL study

Autor: Kahan, Zsuzsanna, Gil-Gil, Miguel, Ruiz-Borrego, Manuel, Carrasco, Eva, Ciruelos, Eva, Muñoz, Montserrat, Bermejo, Begoña, Margeli, Mireia, Antón, Antonio, Casas, Maribel, Csöszi, Tibor, Murillo, Laura, Morales, Serafín, Calvo, Lourdes, Lang, Istvan, Alba, Emilio, de la Haba-Rodriguez, Juan, Ramos, Manuel, López, Isabel Álvarez, Gal-Yam, Einav, Garcia-Palomo, Andrés, Alvarez, Elena, González-Santiago, Santiago, Rodríguez, César A., Servitja, Sonia, Corsaro, Massimo, Rodrigálvarez, Graciela, Zielinski, Christoph, Martín, Miguel
Zdroj: In European Journal of Cancer October 2021 156:70-82
Databáze: ScienceDirect
Externí odkaz: